Daniel 2:28, Inc. is a 501(c)(3) nonprofit research institute that takes an innovative and prayerful approach to designing experiments which reveal discoveries in cancer immunotherapy. The mission statement of Daniel 2:28, Inc. is as follows: Daniel 2:28, Inc exercises fully the authority in Jesus Christ's name to destroy all works of the enemy, specifically cancer, by conducting innovative and original medical research, with an emphasis on cancer immunology. We provide unconventional treatments that may or may not be FDA-approved, to anyone with cancer of any stage, who wants to avoid the inefficacy and toxicity of many traditional chemotherapies. Daniel 2:28, Inc. is not just trying to find an immunologic cure for cancer. We're trying to understand how the immune system is regulated. Immune dysregulation spans from autoimmune disease on one end, to cancer immunosuppression on the other. Multiple sclerosis, allergy, post-transplantation rejection and chimerism, cancer – they all sit on the spectrum of immune dysreglation. We believe that as God reveals to us novel methods of awakening the immune system to recognize cancer, He will unveil much needed ways to stop the immune system from attacking self. Our perspective is a dynamic one, going from the operating table to the clinic to the laboratory bench and back, one afforded only through the observations of surgeon scientists.